Top Markets
Coin of the day
Arch Biopartners Inc. Arch Biopartners Inc.

Arch Biopartners Inc.

ARCH
Kedudukan dalam Saham #25410
Arch Biopartners Inc. is a biotechnology firm dedicated to devising... Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
Harga Saham
$0.73393689
Disegerakkan terakhir: 2026-08-20
Modal Pasaran
$49.86M
Perubahan (1 hari)
-8.26%
Perubahan (1 tahun)
-38.15%
Negara
CA
Perdagangan Arch Biopartners Inc. (ARCH)

Kategori

Sejarah pecahan saham untuk Arch Biopartners Inc. (ARCH)
Saham Arch Biopartners Inc. (simbol: ARCH) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 21, 2026.
Satu saham ARCH yang dibeli sebelum Aug 21, 2026 kini bersamaan dengan 0 saham ARCH.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US